SCHEMBL6921901

SCHEMBL6921901

COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1OCCN1CCCC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 12/20 0.75
HTR1B P28222 9/20 0.75
HTR2A P28223 9/20 0.75
MEN1 O00255 3/20 0.75
MAPT P10636 3/20 0.75
KMT2A Q03164 3/20 0.75
TDP1 Q9NUW8 3/20 0.75
TP53 P04637 2/20 0.75
CYP3A4 P08684 2/20 0.75
CYP2D6 P10635 2/20 0.75
MAPK1 P28482 2/20 0.75
HSD17B10 Q99714 2/20 0.75
HPGD P15428 2/20 0.75
KDM4E B2RXH2 1/20 0.75
ALDH1A1 P00352 1/20 0.75
CYP1A2 P05177 1/20 0.75
ALOX15 P16050 1/20 0.75
SLC6A4 P31645 3/20 0.74
HTR2C P28335 2/20 0.74
CHRM2 P08172 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067303 0.99 HTR1D (0.74) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL7439830 0.95 HTR1D (0.68) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL5317816 0.94 HTR1D (0.73) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL7068863 0.87 HTR1D (0.82) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL6920742 0.86 HTR1D (0.81) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL29390887 0.86 HTR1D (1.00) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL2360553 0.86 HTR1D (1.00) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL6927404 0.86 HTR1D (0.68) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL6928603 0.86 HTR1D (0.68) HTR1DHTR1BHTR2AMEN1MAPT
SCHEMBL6927402 0.86 HTR1D (0.68) HTR1DHTR1BHTR2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed
US-6515027-B1 Ligands, agonists or antagonists, of the CC chemokine receptor CC-CKR5 SMITHKLINE BEECHAM CORP. 2003-02-04 US disclosed
US-5801170-A Heterocyclic biphenylylamides useful as 5HT1D antagonists SMITHKLINE BEECHAM PLC (GB) 1998-09-01 US disclosed
EP-0733048-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-09-25 EP disclosed
WO-1995015954-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-15 WO disclosed